People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DermTech, Inc. | — | Other Health Care | Series C | $98.9M | $1.5B | 2020 |
| Certara, Inc. | — | Other Health Care | Series A | $5.7M | $21.0M | 2025 |
Cynthia Collins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cynthia Collins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gary Jacobs | 1 | 11 |
| Enrico Picozza | 1 | 7 |
| Gene Salkind | 1 | 5 |
| Stephen McLean | 1 | 4 |
| Michael Willis | 1 | 4 |
| Matthew Posard | 1 | 4 |
| Matthew Walsh | 1 | 3 |
| Burkhard Jansen | 1 | 2 |
| Eran Broshy | 1 | 2 |
| Kevin Sun | 1 | 2 |
| John Gallagher III | 1 | 1 |
| Adrian McKemey | 1 | 1 |
| Rona Anhalt | 1 | 1 |
| Daniel Corcoran | 1 | 1 |
| John Reynders | 1 | 1 |
| Robert Aspbury | 1 | 1 |
| Leif Pedersen | 1 | 1 |
| William Feehery | 1 | 1 |
| David Spaight | 1 | 1 |
| Rosemary Crane | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.